Please assess the completion status of the following clinical trial:

Trial Title: Bupropion SR Plus Counseling for Smoking Cessation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Smoke 10 or more cigarettes per day~* Expired carbon monoxide (CO) level greater than 9 parts per million (ppm)~* Motivated to quit smoking (score of 3 on 4-point self-report scale)~* Willing to fulfill study requirements~Exclusion Criteria:~* Carbon monoxide breath test score below 9 ppm~* Serious psychopathology (bipolar disorder, psychosis)~* Center for Epidemiologic Studies Depression Scale CES-D)score over 16~* Contraindications for use of bupropion~* History of seizure disorder~* History of eating disorder~* Current heavy drinking~* Risk of pregnancy~* Current breastfeeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Active bupropion + counseling (Type: ACTIVE_COMPARATOR): Active bupropion SR plus eight 10-minute individual counseling sessions.
- Active bupropion , No counseling (Type: ACTIVE_COMPARATOR): Active bupropion, No counseling, only medication checks
- Placebo medication + counseling (Type: PLACEBO_COMPARATOR): Placebo bupropion plus eight 10-minute individual counseling sessions
- Placebo medication, No counseling (Type: PLACEBO_COMPARATOR): Placebo bupropion, No counseling, just medication checks

Based on this trial design, predict the completion outcome and termination type (if applicable).